PSMA-PET

Phillip Kuo, M.D., Ph.D. | Senior Medical Director

Dr. Phillip Kuo is board-certified in Internal Medicine and Radiology with a special certification in Nuclear Medicine. Prior to taking on the role of Senior Medical Director for Invicro, he was Chief of Nuclear Medicine at a university medical center for 10 years. Dr. Kuo has more than 100 publications and has served as principal investigator and co-principal investigator on multiple NIH grants and investigator-initiated trials. His experience includes design and supervision of phase I-III clinical trials including theranostics with PET, SPECT, MRI, and radiotherapeutics as well as leading the VISION read development. Dr. Kuo’s experience also includes participation in USFDA and EMA meetings for regulatory approval. As a reader for clinical trials, he has reviewed over ten thousand scans for oncology or neurology.

Gisela Montgomery, M.D., Ph.D. | Medical Director

Dr. Gisela Montgomery has seven years of national and international experience in phase I-IV breast cancer clinical imaging trials and has published several scientific peer-reviewed manuscripts in journals, such as Radiology and European Radiology, as first author. She has expertise in protocol design, statistical analysis, imaging evaluation, oncology response criteria (including RECIST 1.1 and PWCG3), regulatory affairs, artificial intelligence, and business development.

Sean Carlin, Ph.D. – Principal Scientist

Dr. Sean Carlin has >25 years of pre-clinical and translational radiopharmaceutical research experience and is an expert in radiation biology. Dr. Carlin also has a particular emphasis on the design and evaluation of radioligands and advanced pre-clinical nuclear imaging techniques. Dr. Carlin has more than 100 peer-reviewed publications and has served as principal investigator and co-principal investigator on multiple US federal grants and sponsored projects. Prior to joining Invicro, he held faculty positions at Weill-Cornell Medical Center, Memorial Sloan Kettering Cancer Center, and The University of Pennsylvania. Dr. Carlin holds a PhD in Molecular Radiopharmacology from the University of Glasgow, Scotland.

Edward Hogan | Executive Vice President, Clinical Operations

Mr. Edward Hogan oversees the Clinical Services team including Project Management, Imaging Services, Data Management and Reader Management for early and late phase clinical trials at Invicro. Mr. Hogan has over twenty-nine years of experience in clinical research, managing and executing Phase 0-IV imaging trials in both the Pharmaceutical and CRO space. He brings more than twenty-one years of experience in managing clinical operations, including extensive experience leading cross-functional teams, including Operations (Project, Image and Data Management), Engineering (Development and Validation) and Medical and Scientific Services. Mr. Hogan has progressive business experience in building and managing global cross-functional teams supporting clinical trials focusing teams on delivery, accountability, and customer satisfaction while driving quality and process improvements.

Beth Rodriguez, CNMT | Vice President, Project Management

Ms. Beth Rodriguez is responsible for the oversight of the project management team, ensuring adequate resource management, coordination of timelines and client communication. Ms. Rodriquez has more than fifteen years of international clinical research and 20+ years of imaging experience. Ms. Rodriquez has successfully managed over 100 large global clinical studies during her career which include various oncology indications ranging from Ph I to Ph III. Beth has extensive experience managing and mentoring remote internal and external global team members across service lines. She has participated in and supported regulatory and client audits (FDA, PMEA). Prior to joining Invicro, Ms. Rodriquez was the Operational Head for 5+ Sponsor Governance Committees.

Elliot Greenblatt, Ph.D. – Principal Scientist, Head of Advanced Special Projects

Dr. Elliot Greenblatt joined Invicro after receiving his Ph.D. in Mechanical Engineering from The Massachusetts Institute of Technology (MIT) in 2015. Dr. Greenblatt has 16+ years of experience in medical image analysis and medical device design. He specializes in developing classical and ML techniques to interpret medical images and in the development of new hardware and software prototypes to image and monitor disease. Prior to joining Invicro, Dr. Greenblatt developed software and hardware to aid the acquisition and analysis of pulmonary functional images. As the current Principal Scientist, Head of Advanced Special Projects, he leads the development and execution of many machine-learning projects on the image analysis team.

Vanessa Kelly, Ph.D. – Director, Oncology & Systemic Disease Image Analysis

Dr. Vanessa Kelly leads the Clinical Oncology and Systemic Diseases Image Analysis team. Dr. Kelly has 12 + years’ experience in clinical and preclinical imaging, biomarker, and drug development in oncology and systemic diseases. During her time at Invicro, Dr. Kelly has worked on several pre-IND programs within the Discovery Research team (In-111/Ac-225 theranostic pairs; Lu-177 targeted radiotherapy; Kelly et. al, Theranostics 2020). More recently, Dr. Kelly has been leading the clinical oncology and systemic disease image analysis team to design, build, and execute image analysis workflows for clinical trials. Specifically, image analysis workflows that incorporate PSMA-PET, FDG-PET, planar-dosimetry, hybrid-dosimetry, and several others. Her role covers software development, management, cross-department collaboration, scientific oversight, and sponsor support.